Millennium Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.15M | Sell |
264,410
-167,050
| -39% | -$5.61M | ﹤0.01% | 2544 |
|
|
2025
Q4 | $18.5M | Buy |
431,460
+326,159
| +310% | +$12.3M | 0.01% | 1656 |
|
|
2025
Q3 | $2.98M | Buy |
105,301
+74,042
| +237% | +$2.21M | ﹤0.01% | 3670 |
|
|
2025
Q2 | $585K | Buy |
+31,259
| New | +$593K | ﹤0.01% | 4796 |
|
|
2025
Q1 | – | Sell |
-70,426
| Closed | -$1.18M | – | 6319 |
|
|
2024
Q4 | $1.18M | Buy |
+70,426
| New | +$1.35M | ﹤0.01% | 4058 |
|
|
2024
Q3 | – | Sell |
-42,467
| Closed | -$349K | – | 6414 |
|
|
2024
Q2 | $349K | Sell |
42,467
-144,832
| -77% | -$1.52M | ﹤0.01% | 4822 |
|
|
2024
Q1 | $2.77M | Buy |
187,299
+109,715
| +141% | +$1.48M | ﹤0.01% | 3450 |
|
|
2023
Q4 | $1.12M | Sell |
77,584
-233,627
| -75% | -$2.39M | ﹤0.01% | 4062 |
|
|
2023
Q3 | $3.36M | Sell |
311,211
-138,365
| -31% | -$1.66M | ﹤0.01% | 3090 |
|
|
2023
Q2 | $5.8M | Sell |
449,576
-74,136
| -14% | -$1M | ﹤0.01% | 2538 |
|
|
2023
Q1 | $6.91M | Buy |
523,712
+204,884
| +64% | +$3.26M | ﹤0.01% | 2303 |
|
|
2022
Q4 | $4.78M | Sell |
318,828
-401,466
| -56% | -$3.68M | ﹤0.01% | 2853 |
|
|
2022
Q3 | $8.5M | Buy |
720,294
+657,630
| +1,049% | +$8.89M | 0.01% | 2345 |
|
|
2022
Q2 | $708K | Sell |
62,664
-187,284
| -75% | -$3.76M | ﹤0.01% | 4682 |
|
|
2022
Q1 | $7.47M | Sell |
249,948
-204,739
| -45% | -$5.54M | ﹤0.01% | 2488 |
|
|
2021
Q4 | $12M | Buy |
454,687
+49,695
| +12% | +$1.5M | 0.01% | 1939 |
|
|
2021
Q3 | $14.7M | Sell |
404,992
-57,966
| -13% | -$2.28M | 0.01% | 1605 |
|
|
2021
Q2 | $20.1M | Buy |
462,958
+95,082
| +26% | +$3.59M | 0.01% | 1192 |
|
|
2021
Q1 | $12.6M | Buy |
367,876
+265,028
| +258% | +$10.5M | 0.01% | 1538 |
|
|
2020
Q4 | $3.6M | Buy |
102,848
+39,464
| +62% | +$1.14M | ﹤0.01% | 2762 |
|
|
2020
Q3 | $1.52K | Buy |
63,384
+6,955
| +12% | +$171K | ﹤0.01% | 2805 |
|
|
2020
Q2 | $1.03M | Sell |
56,429
-759,970
| -93% | -$13.7M | ﹤0.01% | 2972 |
|
|
2020
Q1 | $12.7M | Sell |
816,399
-36,143
| -4% | -$769K | 0.03% | 691 |
|
|
2019
Q4 | $18.2M | Buy |
852,542
+87,730
| +11% | +$1.81M | 0.02% | 916 |
|
|
2019
Q3 | $14.3M | Buy |
764,812
+89,568
| +13% | +$1.85M | 0.02% | 1015 |
|
|
2019
Q2 | $17.6M | Sell |
675,244
-23,287
| -3% | -$526K | 0.03% | 862 |
|
|
2019
Q1 | $18M | Buy |
698,531
+10,951
| +2% | +$250K | 0.03% | 872 |
|
|
2018
Q4 | $15.8M | Sell |
687,580
-75,600
| -10% | -$2.13M | 0.02% | 826 |
|
|
2018
Q3 | $24.5M | Buy |
763,180
+433,172
| +131% | +$13M | 0.03% | 733 |
|
|
2018
Q2 | $9.34M | Sell |
330,008
-70,859
| -18% | -$2.52M | 0.01% | 1358 |
|
|
2018
Q1 | $14.2M | Sell |
400,867
-156,566
| -28% | -$6.27M | 0.02% | 1110 |
|
|
2017
Q4 | $21.6M | Buy |
557,433
+285,441
| +105% | +$10.9M | 0.03% | 855 |
|
|
2017
Q3 | $6.91M | Sell |
271,992
-220,026
| -45% | -$5.35M | 0.01% | 1478 |
|
|
2017
Q2 | $13.4M | Buy |
492,018
+188,149
| +62% | +$5.15M | 0.02% | 887 |
|
|
2017
Q1 | $10.1M | Buy |
303,869
+147,661
| +95% | +$3.76M | 0.02% | 1018 |
|
|
2016
Q4 | $3.72M | Sell |
156,208
-54,061
| -26% | -$1.55M | 0.01% | 1530 |
|
|
2016
Q3 | $7.72M | Sell |
210,269
-26,143
| -11% | -$749K | 0.01% | 1069 |
|
|
2016
Q2 | $5.27M | Buy |
236,412
+1,836
| +0.8% | +$45.6K | 0.01% | 1229 |
|
|
2016
Q1 | $4.88M | Buy |
234,576
+30,016
| +15% | +$740K | 0.01% | 1263 |
|
|
2015
Q4 | $6.2M | Buy |
204,560
+36,816
| +22% | +$1.12M | 0.01% | 1221 |
|
|
2015
Q3 | $4.14M | Sell |
167,744
-7,921
| -5% | -$236K | 0.01% | 1443 |
|
|
2015
Q2 | $5.64M | Sell |
175,665
-6,214
| -3% | -$237K | 0.01% | 1324 |
|
|
2015
Q1 | $6.49M | Sell |
181,879
-15,077
| -8% | -$413K | 0.01% | 1276 |
|
|
2014
Q4 | $4.47M | Sell |
196,956
-108,694
| -36% | -$2.2M | 0.01% | 1465 |
|
|
2014
Q3 | $5.93M | Buy |
305,650
+127,558
| +72% | +$3.6M | 0.02% | 1184 |
|
|
2014
Q2 | $6.46M | Sell |
178,092
-48,436
| -21% | -$1.65M | 0.02% | 1042 |
|
|
2014
Q1 | $8.79M | Sell |
226,528
-101,827
| -31% | -$3.63M | 0.03% | 886 |
|
|
2013
Q4 | $9.36M | Buy |
328,355
+39,283
| +14% | +$1.15M | 0.03% | 759 |
|
|
2013
Q3 | $10.3M | Buy |
289,072
+108,715
| +60% | +$3.97M | 0.03% | 664 |
|
|
2013
Q2 | $6.02M | Buy |
+180,357
| New | +$8.17M | 0.02% | 908 |
|
Other funds holding RIGL
AC
VCM
Millennium Management's RIGL Position: Q1 2026 in Review
Millennium Management reduced its Rigel Pharmaceuticals (RIGL) stake by 39% in Q1 2026, selling an estimated $5.61M and leaving 264,410 shares worth $7.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2544.
Millennium Management first reported a position in RIGL in Q2 2013 and has held it in 50 quarters since. The position peaked at $24.5M in Q3 2018. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Millennium Management held 264,410 shares of Rigel Pharmaceuticals worth $7.15M as of Q1 2026.
- Millennium Management sold 167,050 Rigel Pharmaceuticals shares in Q1 2026, an estimated $5.61M.
- Rigel Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2544 holding.
- Millennium Management first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's Rigel Pharmaceuticals position peaked at $24.5M in Q3 2018.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.